The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

Use vs non-use of sodium-glucose cotransporter 2 inhibitors by older patients with CKD stages 4-5D is significantly associated with reductions in all-cause mortality risk at 6, 12, and 60 months.

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — A study into Medicare beneficiaries with stage 3-5 chronic kidney disease suggests that an ...

Visakhapatnam: A recent pilot study by a group of researchers shows that chronic kidney disease (CKD) is a major but often ...

The impact of chronic kidney disease (CKD) on patients and the health care system in the United States is substantial and expected to increase with the expanding obesity-driven diabetes epidemic. 1 ...